Search:

Login | Subscribe

Home > Companies > AGI Therapeutics

Price	Market	Sector	Market Cap
42.00p (0.00p) 0.00%	AIM	Medicine and Biotech Research	£28.31m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
CBF	2.00p	-11.11%
CRX	2.75p	0.00%
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	28.25p	-2.59%
GMX	1.75p	0.00%
GWP	30.00p	0.00%
HML	0.42p	0.00%
MMG	7.25p	0.00%
MPM	14.25p	0.00%
OMH	3.50p	0.00%
PLE	16.50p	0.00%
PRM	20.50p	-8.89%
PRX	145.00p	5.46%
RNSM	7.75p	0.00%
RCG	35.00p	-6.67%
RGT	6.50p	0.00%

Commentary

Speciality pharmaceutical company focused on gastro-intestinal drug products

Recent Articles

New Issues Examined, by Oliver Haill	13/03/2006
Newcomer - AGI Therapeutics	27/02/2006

Recent Announcements

Director Share Dealing	15/09/2008
Interim Results	09/09/2008
Notice of Results	01/09/2008
Notification of Major Interes	08/08/2008
Research Update	18/07/2008
Research Update	21/05/2008
AGI to present at DDW	14/05/2008
Notice of AGM	13/05/2008
Final Results	03/04/2008
Research Update	02/04/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	EUR	EUR	EUR	EUR
Turnover	0.00	0.00	0.20	0.39
Operating Profit	-2.70	-4.60	-5.15	-15.41
Pretax Profit	-3.12	-5.20	-4.18	-13.89
Earnings After Tax	-3.12	-5.20	-4.32	-14.07
Profit Available For Dividend	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00
Retained Profit	0.00	0.00	0.00	0.00
Shareholders Funds	1.06	-4.13	39.90	26.84
Net Current Assets	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	0.00
Adj Earnings Per Share	0.00	0.00	0.00	0.00
Dividend Per Share	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Adelaide Chambers, Peter Street, Dublin, 8
Telephone	+353 (0)1 449 3250
Fax	+353 (0)1 449 3251
Executives
Chairman	Ronan Lambe (2.10% holding)
Chief Executive	John Devane (15.00% holding)
Finance Director	David Kelly (0.80% holding)
Senior VP Bus. Develop.	Patrick Ashe (2.40% holding)
Main Shareholders
	ACT: 12.1% Seroba: 6% Delta: 6% Bank of Ireland Asset Management : 5.5%
Advisers
Nominated Adviser	Piper Jaffray
Nominated Broker	J&E Davy; Piper Jaffray
Solicitors	Beauchamps
Auditors	KPMG
Registrar	n/a

Commentary
Speciality pharmaceutical company focused on gastro-intestinal drug products
Company Data
Code	AGI
Sedol	IE00B0YT0Q
Shares In Issue	67.413 m
Indices
Entry on AIM	27/02/2006
Interim Results	Sep
Final Results	Apr
Year End	Dec
Accounts Due	n/a
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief